Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer

NCT06471673 is registered in ClinicalTrials.gov with BriaCell Therapeutics Corporation as lead sponsor.

NCT NCT06471673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06471673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
Lead sponsor
BriaCell Therapeutics Corporation
Phase
Phase 1/2
Overall status
Recruiting
Start date
May 29, 2024
Completion date
October 30, 2025
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast tumor, cancer of breast, cancer of the breast, malignant tumor of breast, tumors, breast